The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Second-line chemotherapy for advanced biliary tract cancer after failure of gemcitabine plus platinum: Results of an AGEO multicenter retrospective study.
Bertrand Brieau
No relevant relationships to disclose
Laetitia Dahan
No relevant relationships to disclose
Yann De Rycke
No relevant relationships to disclose
Tarek Boussaha
No relevant relationships to disclose
Philippe Vasseur
No relevant relationships to disclose
David Tougeron
No relevant relationships to disclose
Thierry Lecomte
No relevant relationships to disclose
Romain Coriat
No relevant relationships to disclose
Jean Baptiste Bachet
No relevant relationships to disclose
Pierre Claudez
No relevant relationships to disclose
Aziz Zaanan
No relevant relationships to disclose
Pauline Soibinet
No relevant relationships to disclose
Jérôme Desramé
No relevant relationships to disclose
Anne Thirot-Bidault
No relevant relationships to disclose
Isabelle Trouilloud
No relevant relationships to disclose
Florence Mary
No relevant relationships to disclose
Christophe Locher
No relevant relationships to disclose
Lysiane Marthey
No relevant relationships to disclose
Wulfran Cacheux
No relevant relationships to disclose
Astrid Lievre
No relevant relationships to disclose